Leading Global Pharmaceutical, Biotechnology, and Medical Device companies, as well as Contract and Medical Research Organizations turn to Ancillare to manage their clinical ancillary supplies and equipment to simplify Phase I-IV trial supply demands.
BUILDING THE FOUNDATION
In 2006, Ancillare took the first steps toward creating a first-of-its kind business: one that is wholly dedicated to the discipline of Clinical and Ancillary Supply Chain Management. Work began when a study sponsor challenged Ancillare to fix a critical business problem. The sponsor’s clinical project teams, already weighted by the important and difficult task of getting life-saving therapies to market, were also overwhelmed and distracted by the demands of sourcing, organizing and accounting for all the things necessary to do their work. The logistics of ancillary supply was, in a word, chaotic.
But worse than that, the process of managing ancillary supplies was costly. The sponsor was losing millions each day to the inefficiencies of running their supply chains the old-fashioned way.
Ancillare realized clinical trials needed a singular focus on the supply chain. And out of that need, Ancillare created a new category, which it called Clinical and Ancillary Supply Chain Management.
Ancillare, LP is founded in North Wales, PA.
The Ancillare Professional Team™ (APT) is formed to provide a dedicated management platform for clinical trial supply chain services for each sponsor organization.
Ancillare Global Headquarters established in Horsham, PA.
Ancillare Europe established in Milton Keynes, UK to service the EMEA region.
Ancillare establishes Strategic Depot in Canada.
The Ancillare Supply Chain Management System (ANSUMS™) is implemented, streamlining the process of ancillary product resupply and offering global visibility and reporting across the entire clinical pipeline.
Ancillare’s ESTEEM™ (Executing Shipments Through Effective Enrollment Monitoring) model is deployed. Resupply now matches site-specific patient enrollment rates, aligning distribution on demand.
Ancillare establishes Strategic Depots in Argentina, Brazil, Israel, Mexico, South America, South Korea and Ukraine.
Ancillare’s A-TKO™ first and only end-to-end clinical and ancillary supply chain model is introduced to ensure consistency, accuracy, and cost control throughout the development program lifecycle.
Ancillare Singapore is established in Singapore to service the APAC region.
Ancillare establishes Strategic Depots in China, Japan, Panama, Russia, and Taiwan.
Ancillare celebrates its 10th Anniversary.
Ancillare™’s MedTech Division is established to service medical device and diagnostic trials.
Ancillare served as a key component in 1500 clinical trial in more than 100 countries across 80,000 clinical sites with more than 700,000 patients enrolled.
Ancillare expanded the Global Clinical Operations Department.
Ancillare established Business Development offices in California.
8 of the Top 10 Global Pharmaceutical, 3 of the Top 5 Biotech companies and the Top 3 Global CROs employ Ancillare’s Clinical and Ancillary Supply Chain Management solutions.
Ancillare™ continues its singular, industry-leading mission as the global standard for Clinical and Ancillary Supply Chain Management.
A Singular Focus on Clinical and Ancillary Supply Chain
Ancillare is the only organization of its kind with an exclusive focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics and regulatory experts.
Ancillare’s Turn-Key Operations (A-TKO™) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain.
Our organization is led by our experienced Executive Management Team
Chief Executive Officer and Founder
Joanne Santomauro, Chief Executive Officer and Founder of Ancillare, LP, created the Clinical and Ancillary Supply Chain Management industry in 2006. Prior to the company launch, pharmaceutical, biotechnology, and medical research organizations had little transparency to the overall supply chain and a limited grasp of the associated costs, processes, and regulatory and compliance requirements of this diverse global supply chain. Joanne’s 35 years of supply chain management expertise led the company to launch its market-leading model.
Joanne’s leadership has resulted in her company’s explosive growth throughout the world. Over the last decade, Joanne and her teams were dedicated on innovating, developing, enhancing, and expanding the Ancillare A-TKO™ supply chain model. The model embraces the complexities and globalization of the clinical and ancillary supply chain and manages the chain with a singular focus. This proven flexible and scalable model ensures a transparent and efficient process for sponsors and their CROs.
Joanne successfully completed the Committee of 200 Growing Entrepreneurs Program in 2005, the Tuck School of Business Executive Program in 2008, and she is the recipient of the 2011 Enterprising Women of the Year and Marcum’s Innovator of the Year awards. Joanne was a finalist for the EY Entrepreneur Of The Year® 2018 Award in the Greater Philadelphia region. The company was listed in 2012 and 2014 as one of the fastest growing companies in the region, the 2011 U.S. Department of Commerce Export Achievement Award and the 2014 U.S. Secretary of Commerce Star Award for Excellence in Exports. She serves on the YMWIC Foundation Board, a STEM program dedicated to the advancement of science, technology, engineering, and math for middle through high school students. She holds a Master of Education and is a candidate in the DBA Program at Temple University Fox School of Business.
President and Co-Founder
Jonathan Santomauro is the President and Co-Founder of Ancillare, LP. Prior to Ancillare, he was Vice President of Strategic Development for ISG Office Concepts, Inc. where he focused on supply chain management and solutions for business products for multinational corporations. Jonathan holds a Masters of Business Administration from Cornell University’s Samuel Curtis Johnson Graduate School of Management as well as a Bachelor of Arts from Cornell University.
He is a long-time member of the Advisory Council for Entrepreneurship at Cornell and the Philadelphia Chapter of the YPO (formerly Young President Organization). Jonathan was recognized by the Philadelphia Business Journal as a ‘Forty Under 40’ honoree for 2018.
Executive Vice President, Global Operations and Information Technology
Cathy Porretti is the Executive Vice President of Global Operations and Information Technology at Ancillare, LP. Cathy has more than 28 years of global Supply Chain and Information Technology experience. She has been instrumental in the development of processes and systems to support Ancillare’s global initiatives. Cathy manages people, processes, and systems, as well as the daily operations of the Master Depots in the United States, Singapore, and United Kingdom. In addition, she led the development of the Ancillare Supply Chain Management System (ANSUMS™), a proprietary data-and process-control system, dedicated to the management of the global clinical and ancillary supply chain. Cathy has been an integral contributor to Ancillare’s rapid growth since its inception in 2006.
Executive Vice President, Global Business Development
Michael Brown is the Executive Vice President of Global Business Development at Ancillare, LP. Michael has 25 years of extensive experience in global business development, client relationship and clinical trial management innovations within the pharmaceutical and CRO industries. He has global responsibility for the business development, key account management, and the recently launched medical technology divisions at Ancillare. In addition, he generates innovative ideas and implements processes to increase value and deliver success to all of Ancillare’s customer programs. Michael holds a Bachelor of Business Administration from The Wharton School of the University of Pennsylvania. He also served in the United States Air Force.
JASON BANKS, PhD
Vice President, Clinical Operations
Dr. Jason Banks heads up the Clinical Operations department as the Vice President of Clinical Operations at Ancillare, LP. Jason has more than 20 years of hands-on experience managing global clinical trials, as well as leading strategic clinical and project management groups across the biopharmaceutical industry. Prior to Ancillare, Jason held senior positions at PAREXEL International, Medpace, Inc, IKARIA, and ICON, plc. Jason holds a PhD in in Medicinal Chemistry – Oncology from University of Portsmouth, Portsmouth, England.
Vice President, Supply Chain
Phillip Wilson is the Vice President of Supply Chain at Ancillare, LP. Phillip joined Ancillare in 2017 as a key senior executive responsible for leading all global end-to-end supply chain initiatives and solutions. His current focus is on the strategic development and expansion of Ancillare’s global depot networks and supplier partnerships as well as implementing and executing cost effective sourcing, distribution, and logistics strategies. Prior to his role at Ancillare, Phillip served as Global Director of Global Operational Programs at Catalent Pharma Solutions, where he managed all aspects of the pharmaceutical supply chain. He holds a Masters in Supply Chain Management from Smeal College of Business at The Pennsylvania State University and multiple compliance certifications, such as Transportation and Logistics by APICS (CTL), Business Continuity professional by the DRI International, Certified by the IATA/FIATA as an Air cargo transportation specialist, and licensed by the US Treasury Department as a Customs Broker.
Vice President, Quality
Barbara Falco has been working in quality assurance in the pharmaceutical industry for over 25 years. Barbara joined Ancillare in 2006 as a consultant for quality assurance, regulatory compliance, supplier quality and management. Prior to joining Ancillare, Barbara worked as the head of quality for Kos Pharmaceutical, where she built the quality organization division, supporting research and development, clinical and commercial, and led the division through the company’s growth. Barbara has extensive experience managing and auditing suppliers as well as working in quality assurance and control in the API industry.
She spent more than 10 years on the board of directors of the International Pharmaceutical Aerosol Consortium (IPAC-RS), where she served as the chair of the supplier quality working group and co-chair of the materials working group. Barbara continues to serve as a science advisor for IPAC-RS.
JEANNINE R. DWYER
Vice President, Finance
Jeannine R. Dwyer is the Vice President of Finance at Ancillare, LP. Jeannine joined Ancillare in February 2018, bringing over 20 years of financial leadership experience in both public and private organizations, with direct experience in M&A transactions, IPOs, SOX Compliance, Internal Audit, International Financial Reporting, and FP&A. Jeannine is responsible for driving the organization’s financial vision and leading the global financial and accounting operations. Prior to Ancillare, Jeannine spent over 14 years at BioClinica, where she held various financial roles with her last position as Vice President of Finance. Jeannine began the earlier part of her career in Assurance at PricewaterhouseCoopers in CT and CA, followed by international accounting experience at Deloitte Consulting. Jeannine further went on to work at the Wells Fargo in the SEC Reporting department and worked directly with key financial and operational leaders at corporate headquarters. Jeannine is an active Certified Public Accountant (CPA) and holds a Bachelor of Science in Accounting from Fairfield University.
Vice President, Commercial Operations
Andrew Billimore is the Vice President of Commercial Operations at Ancillare, LP. Andrew has 15 years of leadership experience in IMP Storage and Distribution, Biological Specimen Logistics & Kit Manufacturing, and Ancillary Clinical Trial Supplies. His focus is on developing multinational key global relationships by providing leadership to dedicated commercial development teams. Andrew has effectively facilitated strategy and growth for global regions of the world’s largest specialty clinical supply chain organizations, while based in Europe and the United States.
Vice President, Asia-Pacific
Nitin Jain serves as Vice President of Asia-Pacific at Ancillare, LP. Nitin’s focus is on driving operational excellence to support our client’s clinical and ancillary supply chain needs and oversee the complete end-to-end supply chain management operations of Ancillare’s Singapore Master Depot. Nitin brings over 20 years of business development, general management, strategic alliances, supply chain management and operations experience in pharmaceutical, biotechnology and contract research organizations around the world. Prior to Ancillare, Nitin has held senior positions at INC Research, Covance, Theorem Clinical Research and Worldwide Clinical Trials. Nitin holds a Master of Business Administration from the American College in London.
Vice President, Strategy
David Peters is the Vice President of Strategy at Ancillare, LP. David brings more than 30 years of experience in leadership, clinical development, strategic partnerships, financial reporting, operational optimization, and strategic planning within clinical trial organizations. David’s focus is to lead key growth initiatives, global development, and overall strategic direction for Ancillare. Among his strategic focus areas, David will be championing the Ancillare Turn-Key Operation (A-TKO™) model as a solution for study sponsors and CROs with complex, global clinical trials. He will also provide thought leadership for the Clinical Operations in the organization. David has held executive leadership positons at BioClinica, WCCT Global, inVentiv Health, and ICON, plc. David is a Certified Public Accountant (CPA) with a Bachelor of Science in Accounting and Computer Science from Johnson & Wales University.
DAVID DELCOLLO, ESQ.
David J. DelCollo, Esquire is the In-House Counsel at Ancillare, LP. David started with Ancillare in 2017, bringing more than a decade of legal experience with him as primary counsel to the organization, providing legal support for Ancillare’s global business. Prior to joining Ancillare, David served as Senior Counsel and General Counsel for various organizations including Bioclinica, Cardinal Innovations Healthcare and Acsys. David holds a Juris Doctor from Widener University Commonwealth School of Law.
At Ancillare, our mission is to maintain the integrity, quality and flow of the global pharmaceutical supply chain so our customers can focus on their mission to develop innovative therapies for patients.
As one of the leading partners providing clinical services today, Ancillare has built the experience, expertise and network necessary to ensure protocol success from start to finish. Headquartered near Philadelphia, PA (USA) we have successfully managed the global clinical and ancillary supply chain for sponsor organizations of all sizes and therapeutic areas.
Ancillare’s unique and dynamic clinical trials process management services include ancillary and clinical supplies management, regulatory compliance services and global logistics management. Each Ancillare Professional Team (APT™) provides the flexible staff augmentation necessary to service the largest and most complex modern protocols. Our services are supported by our customized ANSUMS™ system, which enhances process visibility and accountability across the supply chain.
Ancillare provides consistency and predictability in a global, decentralized system. Our end-to-end process management services are designed to help ensure protocol success, and our track record demonstrates our commitment to global excellence. Operating in more than 100 countries globally, Ancillare can manage the flow of supplies and equipment from start to finish, ensuring authenticity and efficiency to positively impact both local and global communities. Our goal is to lead the field in customized solutions for our partners, allowing them to produce the therapies needed to combat global illnesses.
All Ancillare employees comply with the company’s ethics policy, code of conduct and local laws and regulations. We respect the privacy of employees and clients and the human rights of our global employees, partners, and vendor network.
We work together with our clients to understand and assess their needs and develop customized programs to meet their objectives.
We are invested in the global clinical supply chain. Our standards are a result of our ability to deliver superior solutions to our clients. We strive to constantly improve our processes and rise to any challenge presented in a protocol or in the field.
Our goal is to provide a robust supply chain to ensure protocol success. We work with our clients to develop innovative solutions to their problems and optimize processes, even if the solutions are absent in the marketplace today. We strive to exceed goals in every engagement and work to build the flexible programs needed for success.
Communicative & Transparent
We strive to create an open channel of communication with our partners at every step in the process. Information is the most valuable tool in any system, and our programs are designed to keep stakeholders informed and provide updates and notifications at every opportunity.
We work to build strategies based on the input of cross-functional teams. We leverage the combined experience and expertise of our teams to create action plans to meet the changing global environment. Our programs are designed to ensure open communication and collaboration within our company and with our clients and partners.
Ancillare believes we are an integral part of the global community. Socially responsible behavior provides long-term value to our clients, employees, partners, and the communities in which we live and work and is necessary for business sustainability and growth.
Our corporate culture demands that we act responsibly, complying fully with all applicable ethics policies, regulations and regulatory guidelines while ensuring all the work we do — from sourcing to distribution to destruction or reclamation — is conducted in a manner that is responsible to all the communities in which we operate.
Furthermore, individually and in teams, we participate in a variety of activities focused on children, underserved communities, health and animal welfare. Our employees regularly organize and host fundraising activities to raise awareness and funds to support these organizations, which include:
…and many more!